PTEN – clinical significance in colorectal cancer
Journal Title: OncoReview - Year 2016, Vol 6, Issue 2
Abstract
Phosphatase and tensin homolog deleted on chromosome ten (PTEN ) is a human suppressor gene. Its protein product is a bispecific phosphatase playing the complex role in the cell cycle regulating processes and apoptosis by the mechanism of signal transduction into the cell via tyrosine kinase B signaling pathway (PI3K/Akt/mTOR). Reduction or loss of PTEN function is implicated in the pathogenesis of many malignancies, including colorectal cancer. A gradual decrease in the function of PTEN in the sequence of transformations: normal tissue polyp–adenocarcinoma – disseminated cancer was indicated. The relation between the PTEN loss and the higher clinical severity of colorectal cancer was observed, i.a. higher TNM status and higher tendency to form metastases, leading in some of the studies to shortened patients survival during the observation period. The potential predictive value of the PTEN function loss for the EGFR-targeted therapy in patients with advanced colorectal cancer is the subject of controversy. The potential application of PTEN assessment in clinical practice as a prognostic and/or predictive factor requires further well designed prospective studies on larger patient population, using the unified methodology.The aim of the study is to summarize the current knowledge on the role of PTEN gene and PTEN protein in the pathogenesis of colorectal cancer and the role of PTEN in clinical practice.
Authors and Affiliations
Angelika Copija, Dariusz Waniczek, Katarzyna Walkiewicz, Łukasz Głogowski, Henryk Augustyniak, Ewa Nowakowska-Zajdel
Keywords
Related Articles
- EP ID EP78746
- DOI 10.5604/20828691.1207995
- Views 231
- Downloads 0
The management and outcome of essential thrombocythemia in pregnancy - single-center experience
Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by an increase in platelet (PLT > 450 000/μl) and a tendency for either thrombosis or hemorrhage. ET is often diagnosed in elderly life...
Breast cancer heterogeneity - report from IMPAKT Breast Cancer Conference
On 2–4 May 2013, in Brussels took place the 5th IMPAKT conference on translational research in breast cancer. The most important issue raised during the conference was the phenomenon of breast cancer heterogeneity, both...
Nefrotoksyczność leków stosowanych w chemioterapii nowotworów
Rozwój onkologii klinicznej oraz coraz częstsza zapadalność na nowotwory powodują szybkie zwiększanie się grupy chorych leczonych chemioterapeutykami. Stosowanie tych leków oprócz korzyści niesie ze sobą również ryzyko w...
Angioplastyka wieńcowa oraz wymiana zastawki aortalnej u dwóch chorych ze szpiczakiem mnogim - opisy przypadków
Szpiczak mnogi jest schorzeniem hematologicznym charakteryzującym się klonalnym rozrostem atypowych plazmocytów, produkujących monoklonalną immunoglobulinę. Roczna zapadalność na niego w Europie wynosi ok. 4,5/100 000 os...
Hemoptysis – cancer or pulmonary embolism?
Oncological patients are a group at risk of venous thromboembolism. Hemoptysis may occur as an element of pulmonary embolism, as well as a result of malignancy. Hemoptysis always requires urgent and unequivocal diagnosti...